RAMM Pharma Corp. (CSE:RAMM)
Canada
· Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Apr 20, 2026, 9:04 AM EST
RAMM Pharma Balance Sheet
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 0.99 | 0.8 | 0.81 | 5.12 | 9.77 | 17.16 | Upgrade
|
| Cash & Short-Term Investments | 0.99 | 0.8 | 0.81 | 5.12 | 9.77 | 17.16 | Upgrade
|
| Cash Growth | 105.10% | -1.25% | -84.09% | -47.65% | -43.03% | -38.74% | Upgrade
|
| Accounts Receivable | 0.11 | 0.45 | 0.78 | 0.62 | 0.92 | 1.17 | Upgrade
|
| Other Receivables | 0.34 | 0.43 | 0.86 | 1.26 | 1.83 | 2.78 | Upgrade
|
| Receivables | 0.45 | 0.88 | 1.64 | 1.88 | 2.74 | 3.95 | Upgrade
|
| Inventory | 0.88 | 0.93 | 2.54 | 3.14 | 4.02 | 3.05 | Upgrade
|
| Prepaid Expenses | 0.02 | 0.03 | 0.26 | 0.22 | 0.08 | 0.06 | Upgrade
|
| Other Current Assets | 0 | 0 | 0.1 | 0.24 | 0.03 | 0.06 | Upgrade
|
| Total Current Assets | 2.34 | 2.64 | 5.36 | 10.59 | 16.65 | 24.28 | Upgrade
|
| Property, Plant & Equipment | 6.11 | 6.63 | 11.2 | 19.05 | 19.71 | 19.34 | Upgrade
|
| Goodwill | - | - | - | - | - | 12.85 | Upgrade
|
| Other Intangible Assets | 0 | 0 | 0.19 | 0.49 | 0.8 | 1.47 | Upgrade
|
| Other Long-Term Assets | - | - | - | 2.17 | 2.08 | 1.86 | Upgrade
|
| Total Assets | 8.45 | 9.27 | 16.75 | 32.3 | 39.24 | 59.8 | Upgrade
|
| Accounts Payable | 0.19 | 0.38 | 0.64 | 1.21 | 1.11 | 1.93 | Upgrade
|
| Accrued Expenses | 0.23 | 0.28 | 0.36 | 0.33 | 0.56 | 0.48 | Upgrade
|
| Current Portion of Leases | 0.06 | 0.07 | 0.1 | 0.23 | 0.23 | 0.03 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Other Current Liabilities | 3.08 | 2.83 | 1.92 | 0.87 | 1.3 | 0.87 | Upgrade
|
| Total Current Liabilities | 3.56 | 3.56 | 3.03 | 2.66 | 3.2 | 3.32 | Upgrade
|
| Long-Term Leases | - | 0.01 | 0.08 | 0.18 | 0.45 | 0 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.09 | Upgrade
|
| Total Liabilities | 3.56 | 3.57 | 3.11 | 2.84 | 3.66 | 3.41 | Upgrade
|
| Common Stock | 60.99 | 60.99 | 60.99 | 60.99 | 62.52 | 63.06 | Upgrade
|
| Additional Paid-In Capital | 7.17 | 7.17 | 6.87 | 3.05 | 1.36 | 1.36 | Upgrade
|
| Retained Earnings | -75.58 | -74.82 | -65.91 | -49.45 | -43.09 | -22.44 | Upgrade
|
| Comprehensive Income & Other | 12.31 | 12.36 | 11.69 | 14.88 | 14.79 | 14.42 | Upgrade
|
| Shareholders' Equity | 4.89 | 5.7 | 13.63 | 29.46 | 35.59 | 56.39 | Upgrade
|
| Total Liabilities & Equity | 8.45 | 9.27 | 16.75 | 32.3 | 39.24 | 59.8 | Upgrade
|
| Total Debt | 0.06 | 0.08 | 0.19 | 0.41 | 0.68 | 0.03 | Upgrade
|
| Net Cash (Debt) | 0.92 | 0.72 | 0.63 | 4.71 | 9.09 | 17.12 | Upgrade
|
| Net Cash Growth | 226.82% | 15.62% | -86.72% | -48.16% | -46.92% | -38.64% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.01 | 0.01 | 0.04 | 0.07 | 0.16 | Upgrade
|
| Filing Date Shares Outstanding | 119.39 | 119.39 | 119.39 | 119.39 | 122.4 | 123.45 | Upgrade
|
| Total Common Shares Outstanding | 119.39 | 119.39 | 119.39 | 119.39 | 122.4 | 123.45 | Upgrade
|
| Working Capital | -1.22 | -0.92 | 2.33 | 7.93 | 13.45 | 20.97 | Upgrade
|
| Book Value Per Share | 0.04 | 0.05 | 0.11 | 0.25 | 0.29 | 0.46 | Upgrade
|
| Tangible Book Value | 4.89 | 5.69 | 13.45 | 28.97 | 34.78 | 42.07 | Upgrade
|
| Tangible Book Value Per Share | 0.04 | 0.05 | 0.11 | 0.24 | 0.28 | 0.34 | Upgrade
|
| Land | 1.43 | 2.48 | 3.7 | 4.58 | 4.42 | 4.18 | Upgrade
|
| Machinery | 5.41 | 5.5 | 5.66 | 6.06 | 5.82 | 4.76 | Upgrade
|
| Construction In Progress | 3.26 | 3.3 | 6.32 | 12.05 | 11.96 | 12.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.